천식, COPD, 폐렴과 같은 호흡기질환의 유병률 증가로 병원 및 재택 간호 환경에서 지속적인 호흡 모니터링에 대한 수요가 증가하고 있습니다. 또한, 전 세계적으로 외과 수술이 증가함에 따라 정확한 마취 모니터링의 필요성이 증가하고 있으며, 호흡 가스 모니터는 환자의 안전을 보장하기 위해 산소 및 CO2 수준을 추적하는 데 중요한 역할을 하고 있습니다. 효과적인 마취 치료에 대한 수요 증가와 기술 발전으로 인해 시장의 주요 업체들은 더 많은 제품을 출시하고 규제 당국의 승인을 받고 있습니다. 무선 연결 및 실시간 데이터 분석과 같은 향상된 기능을 갖춘 이러한 새로운 장치는 의료 제공자와 환자의 진화하는 요구를 충족시킴으로써 시장 성장을 더욱 촉진하고 있습니다. 이러한 요인들이 결합되어 2024년부터 2030년까지 예측 기간 동안 호흡 가스 모니터 시장은 활기를 띨 것으로 예상됩니다.
호흡 가스 모니터 : 시장 역학
Australian Institute of Health and Welfare의 최신 데이터에 따르면, 2022년 호주에서 약 850만 명(34%)이 만성 호흡기질환을 앓고 있는 것으로 추산됩니다.
또한, Global Burden of Disease(2023년)의 최신 데이터에 따르면, 전 세계 인구 약 20명 중 1명이 만성 호흡기질환을 앓고 있다고 합니다.
또한, 세계보건기구(WHO)가 제공한 최근 데이터와 통계(2024년)에 따르면, 천식은 전 세계적으로 약 2억 6,200만 명이 앓고 있는 것으로 추산됩니다. 천식, 만성폐쇄성폐질환(COPD), 폐 감염과 같은 호흡기질환의 증가는 호흡 가스 모니터 시장을 크게 견인하고 있습니다. 산소, 이산화탄소 및 기타 호흡 가스의 지속적인 모니터링이 필요한 환자가 증가함에 따라 병원과 클리닉은 더 나은 치료를 제공하기 위해 고급 모니터링 시스템을 채택하고 있습니다. 이러한 장비는 호흡 곤란의 조기 징후를 감지하고 치료 계획을 최적화하며 환자 결과를 개선하는 데 도움이됩니다. 만성 호흡기질환의 증가로 인해 의료 시설과 가정에서 장기 모니터링의 필요성이 증가함에 따라 휴대용 비 침습적 호흡 가스 모니터에 대한 수요가 더욱 증가하고 있습니다.
기기별로는 맥박 산소 측정기가 2023년 상당한 시장 점유율을 차지했습니다. 맥박 산소측정기는 환자의 산소포화도(SpO2)와 심박수를 모니터링할 수 있는 비용 효율적인 비침습적 솔루션을 제공함으로써 전체 호흡 가스 모니터 시장에 큰 영향을 미치고 있습니다. 병원, 외래 진료소, 재택 진료 등 다양한 의료 환경에서 호흡 모니터링 솔루션에 대한 수요가 증가함에 따라 호흡 모니터링 솔루션에 대한 수요가 증가하고 있습니다. 특히 만성폐쇄성폐질환(COPD), 천식 등 호흡기질환을 앓고 있는 환자 관리 및 수술 시 맥박 산소포화도 측정기가 제공하는 사용 편의성과 빠른 결과는 의료 서비스 제공자에게 필수적인 도구가 되고 있습니다.
세계 호흡 가스 모니터 시장을 조사했으며, 시장 개요, 시장 영향요인 및 시장 기회 분석, 규제 환경, 시장 규모 추정 및 예측, 각종 부문별·지역별·주요 국가별 상세 분석, 경쟁 구도, 주요 기업 개요 등의 정보를 정리하여 전해드립니다.
Respiratory Gas Monitors Market by Device (Capnographs, Pulse Oximeters, Spirometers, and Others), End-User (Hospitals, Clinics, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR forecast till 2030 owing to the rising prevalence of respiratory disorders, increasing number of surgical procedures across the globe, and growing demand for anesthesia monitoring.
The rising prevalence of respiratory disorders, such as asthma, COPD, and pneumonia, is driving the demand for continuous respiratory monitoring in hospitals and homecare settings. Additionally, the increasing number of surgical procedures worldwide has heightened the need for precise anesthesia monitoring, where respiratory gas monitors play a critical role in tracking oxygen and CO2 levels to ensure patient safety. The growing demand for effective anesthesia care and rising advancements in technology, leading to more product launches and regulatory approvals by key players in the market. These new devices, equipped with enhanced features like wireless connectivity and real-time data analysis, further fuel market growth by meeting the evolving needs of healthcare providers and patients globally. Together, these factors are expected to boost the market of respiratory gas monitors during the forecast period from 2024 to 2030.
Respiratory Gas Monitors Market Dynamics:
According to the latest data provided by the Australian Institute of Health and Welfare, in 2022, around 8.5 million (34%) people in Australia were estimated to have chronic respiratory conditions.
Additionally, as per the recent data provided by the Global Burden of Disease (2023), approximately, 1 in 20 people globally suffered from chronic respiratory diseases.
Furthermore, according to the recent data and stats provided by World Health Organization (2024), asthma affected an estimated 262 million people globally. The increase in respiratory disorders, such as asthma, chronic obstructive pulmonary disease (COPD), lung infections is significantly driving the market for respiratory gas monitors. With a growing number of patients requiring continuous monitoring of oxygen, carbon dioxide, and other respiratory gases, hospitals and clinics are adopting advanced monitoring systems to provide better care. These devices help detect early signs of respiratory distress, optimize treatment plans, and improve patient outcomes. The rise in chronic respiratory conditions also increases the need for long-term monitoring, both in healthcare facilities and at home, further boosting the demand for portable and non-invasive respiratory gas monitors.
According to the Global Surgery Foundation 2021 reports, about 30% of the global burden of disease is caused by conditions that can be treated by surgery. The increase in surgical procedures globally is driving the demand for respiratory gas monitors, as these devices play a vital role in patient safety during anesthesia administration. Accurate monitoring of gases like oxygen, carbon dioxide, and anesthetic agents is crucial to ensure proper ventilation and prevent complications such as hypoxia or hypercapnia. As the number of surgeries rises-particularly in areas such as cardiovascular, orthopedic, and bariatric procedures-the need for advanced anesthesia monitoring systems grows and thus the demand for respiratory gas monitors esclates. Additionally, complex surgeries often require prolonged anesthesia, making continuous respiratory monitoring essential in both operating rooms and post-anesthesia care units (PACUs). Thus, the adoption of respiratory gas monitors is further bolstered by the rise in number of surgical procedures, where real-time gas monitoring supports quicker patient recovery and discharge.
Thus, the factors mentioned above are likely to boost the market of respiratory gas monitors during the forecasted period.
However, the increased product recalls for respiratory gas monitors and stringent regulatory concerns for product approval may hinder the future market of respiratory gas monitors.
Respiratory Gas Monitors Market Segment Analysis:
Respiratory Gas Monitors Market by Device (Capnographs, Pulse Oximeters, Spirometers, and Others), End-User (Hospitals, Clinics, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)
In the device segment of the respiratory gas monitors market, pulse oximeters are projected to hold a considerable market share in 2023. Pulse oximeters have significantly influenced the overall market of respiratory gas monitors by providing a cost-effective, non-invasive solution for monitoring patients' oxygen saturation levels (SpO2) and heart rates. Their widespread adoption across various healthcare settings, including hospitals, outpatient clinics, and home care, has driven demand for respiratory monitoring solutions. The ease of use and rapid results offered by pulse oximeters make them an essential tool for healthcare providers, especially in the management of patients with respiratory disorders such as chronic obstructive pulmonary disease (COPD), asthma, and during surgical procedures.
Additionally, the increasing prevalence of respiratory illnesses, coupled with the rising emphasis on remote patient monitoring and telehealth services, has propelled the demand for pulse oximeters, leading to enhanced integration with other respiratory monitoring systems. For instance, as per the recent data provided by the World Health Organization (2023), smoking was a major cause of chronic obstructive pulmonary disease, a common lung condition that led to breathing difficulties and claimed over 3 million lives annually. Approximately 392 million people had COPD, with about 75% living in low- and middle-income countries. In high-income countries, tobacco smoking was responsible for over 70% of COPD cases. Patients with COPD often experience hypoxemia (low blood oxygen levels), necessitating continuous monitoring to ensure appropriate oxygen therapy and prevent exacerbations. Pulse oximeters provide a non-invasive, rapid, and accurate means to assess oxygen saturation levels in patients, enabling healthcare providers to make timely decisions regarding treatment adjustments.
Additionally, the increasing product approval across the globe are further propelling the market of the segment. In February 2024, Masimo announced FDA clearance of MightySat(R) Medical, making it the first and only FDA-cleared medical fingertip pulse oximeter available Over-The-Counter (OTC) direct to consumers without a prescription.
Therefore, owing to the above-mentioned factors, the pulse oximeter category is expected to generate considerable revenue thereby pushing the overall growth of the global respiratory gas monitors market during the forecast period.
North America is expected to dominate the overall respiratory gas monitors market:
Among all the regions, North America is expected to hold the largest share in the global Respiratory Gas Monitors market in 2023. The rising prevalence of respiratory disorders, such as asthma and Chronic Obstructive Pulmonary Disease (COPD), is driving the need for effective monitoring solutions to manage these conditions. Additionally, the growing number of surgical procedures and the heightened focus on patient safety and anesthesia management further contribute to market growth. Furthermore, significant investments in research and development by leading medical device companies in North America are resulting in innovative product launches and technological advancements, enhancing the efficacy and usability of respiratory gas monitors.
According to the recent data and stats provided by American Lung Association (2024), asthma accounted for 10.8% for females and 6.5% for males across the region of United States. Additionally, as per the data provided by the Centre for Disease Control and Prevention (2024), in 2022, 4.6% of adults had been diagnosed with COPD, emphysema, or chronic bronchitis in the United States. COPD, characterized by airflow limitation and respiratory symptoms, often leads to hypoxemia, requiring continuous oxygen saturation monitoring to adjust therapies appropriately. Similarly, asthma patients face variable airflow obstruction, which can lead to acute episodes, making real-time monitoring of respiratory gases essential for timely interventions. Therefore, the rising prevalence of Chronic Obstructive Pulmonary Disease (COPD) and asthma is significantly boosting the market for respiratory gas monitors, as these conditions necessitate effective monitoring and management to ensure optimal patient outcomes.
Furthermore, the increasing number of product development activities in the region is further going to accelerate the growth of the respiratory gas monitors market. For instance, in August 2021, Roundworks Technologies Private Limited announced the approval of 510(k) for its alveoair Digital Spirometer. alveoair(R) is a personal spirometer designed for asthma, COPD, cystic fibrosis and ILD patients to help quantify their lung health.
Therefore, the factors mentioned above are expected to boost the growth of the respiratory gas monitors market in the North America region during the forecast period from 2024 to 2030.
Respiratory Gas Monitors Market Key Players:
Some of the key market players operating in the respiratory gas monitors market include Medtronic plc., Koninklijke Philips N.V., Nihon Kohden Corporation, Dragerwerk AG & Co. KGaA, Stryker, GE Healthcare, ndd Medical Technologies, VYAIRE, Baxter, Contec, Zoll Medical Corporation, ICU Medical, Hamilton Medical, Avante Health Solutions, Nonin, BD, EDAN Instruments, Inc., Criticare Technologies, Inc., and HILLROM, and others.
Recent Developmental Activities in the Respiratory Gas Monitors Market:
Key Takeaways From the Respiratory Gas Monitors Market Report Study:
Target Audience who can be Benefited From This Respiratory Gas Monitors Market Report Study: